147 results
8-K
EX-99.1
NUWE
Nuwellis Inc
7 May 24
Nuwellis, Inc. Announces First Quarter 2024 Financial Results
11:02am
treatments must be administered by a health care provider, within an outpatient or inpatient clinical setting, under physician prescription, both having
8-K
EX-99.1
NUWE
Nuwellis Inc
30 Apr 24
Nuwellis Announces Pricing of $2.7 Million Public Offering
6:25pm
20 kg or more whose fluid overload is unresponsive to medical management, including diuretics. All treatments must be administered by a health care provider
8-K
EX-10.1
NUWE
Nuwellis Inc
30 Apr 24
Nuwellis Announces Pricing of $2.7 Million Public Offering
6:25pm
respects; and to the Company’s knowledge, there are no health care laws which as of this date are material to the business of the Company which
8-K
EX-99.2
NUWE
Nuwellis Inc
30 Apr 24
Nuwellis Announces Pricing of $2.7 Million Public Offering
6:25pm
whose fluid overload is unresponsive to medical management, including diuretics. All treatments must be administered by a health care provider, within
424B4
gxlk7lxe yn188wr8
29 Apr 24
Prospectus supplement with pricing info
4:58pm
8-K
EX-99.1
s1xihjaz72 30irxkujb
6 Mar 24
Nuwellis, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results
12:02pm
8-K/A
EX-99.1
pxqfethe smkykd
9 Jan 24
Regulation FD Disclosure
5:30pm
8-K
EX-99.1
x6ht0al
8 Jan 24
Regulation FD Disclosure
9:24am
8-K
EX-99.1
21nqpncnpfh 5ft5p
7 Nov 23
Nuwellis, Inc. Announces Third Quarter 2023 Financial Results
8:15am